Skip To Main Content
Norbert Gattermann on Muck Rack

Norbert Gattermann

As seen in: Color Research & Application, MDPI, Taylor & Francis Online, Rapporteur
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Norbert Gattermann’s profile

Articles by Norbert Gattermann

Luspatercept as a therapy for myelodysplastic syndromes with ring sideroblasts

|
By Norbert Gattermann, Ulrich Germing
| Taylor & Francis Online
Felicitas SchulzDepartment of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, GermanyView further author information , Kathrin NachtkampDepartment of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, GermanyView further author information , Annika KasprzakDepartment of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, GermanyView further author information , Norbert...
Open in Who Shared Issue with article?

Revisiting the use and management of blood in Europe, in times of crisis and beyond

|
By Axel Hofmann, Norbert Gattermann, Androulla Eleftheriou
| Rapporteur Verified
Open in Who Shared Issue with article?

Effect of deferasirox + erythropoietin vs erythropoietin on erythroid response in Low/Int‐1‐risk MDS patients: Results of the phase II KALLISTO trial

|
By Norbert Gattermann, Rosa Coll, Lutz Jacobasch, Allameddine Allameddine
| Color Research & Application Verified
Erythropoiesis‐stimulating agents (ESAs) remain first‐choice to treat symptomatic anemia and delay transfusion dependence in most patients with lower‐risk myelodysplastic syndromes (MDS) without del(5q). Deferasirox increased erythroid responses in some lower‐risk MDS patients in clinical trials, and adding low‐dose deferasirox to ESA treatment may further improve erythroid response. KALLISTO (NCT01868477) was a randomized, open‐label, multicenter, phase II study.
Open in Who Shared Issue with article?
Show More